111 Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
111 Capital's BMY Position: Q3 2026 in Review
111 Capital increased its Bristol-Myers Squibb (BMY) stake by 105% in Q3 2026, buying an estimated $360K and bringing the position to 11,113 shares worth $693K. The position accounts for 0.1% of the portfolio, ranked #232.
111 Capital first reported a position in BMY in Q4 2024 and has held it in 5 quarters since. The position peaked at $992K in Q4 2024. 2,549 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- 111 Capital held 11,113 shares of Bristol-Myers Squibb worth $693K as of Q3 2026.
- 111 Capital bought 5,694 Bristol-Myers Squibb shares in Q3 2026, an estimated $360K.
- Bristol-Myers Squibb made up 0.1% of 111 Capital's portfolio in Q3 2026, its #232 holding.
- 111 Capital first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 5 quarters since.
- 111 Capital's Bristol-Myers Squibb position peaked at $992K in Q4 2024.
- 2,549 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on 111 Capital's 13F filing for Q3 2026, filed 3 Nov 2026.